TORONTO, Jan. 26 /PRNewswire-FirstCall/ -- MedCap Corporation (Pinksheets: MPCPF) is please to announce that it has signed distributorship agreements for the AccuScan test kits with three established medical products supply companies in S.E. Asia. Based on their current client base and the anticipated demand it is reasonable to expect that they will purchase in excess of 300,000 test kits each in the first year. The contracts require that they purchase a minimum of 400,000 test kits per year for an additional two years. These contracts have a potential value to MedCap of $8,200,000 USD over the life of the contracts.
MedCap Corp trades in the United States on the Pinksheets under the symbol "MPCPF". For further information, please contact Cazgeld Capital Corporation at (416) 363 0070 or at http://www.medccorp.com/.
NOTE: This release may contain forward-looking statements that involve uncertainties and risks. Actual results may differ materially from any results predicted. MedCap undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events of circumstances after the date hereof
CONTACT: Cazgeld Capital Corporation, +1-416-363-0070, for MedCapCorporation